Utility of Chinese Versions of Addenbrooke's Cognitive Examination: A Narrative Review

Healthcare (Basel). 2022 Oct 17;10(10):2052. doi: 10.3390/healthcare10102052.

Abstract

Addenbrooke's cognitive examination (ACE) is a cognitive screening tool that has developed through three stages: ACE, ACE-Revised (ACE-R), and ACE-Ⅲ. In addition, mini-Addenbrooke's Cognitive Examination (M-ACE) and ACE mobile are the additional versions that is derived from ACE-III. ACE and its related versions show better performance than Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) in detecting mild cognitive impairment in different neurological disorders. It has been translated into numerous languages, including Chinese. Through reviewing the history, validity, and comparison with other cognitive tests of Chinese versions of ACE, it aims to facilitate the clinical and scientific use, further development, improvement, and validation of Chinese versions of ACE in various neurological disorders and ultimately promote early identification and management of cognitive impairment in China.

Keywords: Addenbrooke’s cognitive examination; Chinese; clinical examination; dementia; mild cognitive impairment.

Publication types

  • Review